Therapeutic Use Exemption Process
Therapeutic Use Exemption application processing
ASDMAC have 21 days to consider and provide the outcome regarding a Therapeutic Use Exemption application if all the necessary supporting medical evidence is provided. If an application is incomplete, it will be returned to the athlete and more information may be requested.
If ASDMAC approves the TUE application a TUE certificate will be provided to the athlete, with copies sent to the athlete’s doctor and the athlete’s relevant sporting administration body.
TUEs last for different lengths of time depending on the substance, from a number of weeks to a number of years. It is the athletes’ responsibility to check the expiry date and apply for a renewal if they are still taking the medication.
A TUE granted by ASDMAC and administered by Sport Integrity Australia is only valid at the national-level and, should you become an international-level athlete or compete at Major Games, your TUE will not be valid unless it is recognised by the relevant International Federation (IF) or Major Event Organisation (MEO). ASDMAC will help the athlete seek recognition of their TUE from the IF or MEO.
TUE applications are processed in accordance with the WADA International for Therapeutic Use Exemptions (ISTUE).
Submitting Therapeutic Use Exemption applications
Therapeutic Use Exemption applications should be sent to:
Post: PO Box 1744, Fyshwick ACT 2609
Unsuccessful TUE applications
Should an athlete's TUE not be approved by ASDMAC they can:
- Submit new supporting documentation and request that ASDMAC reconsider their application.
- If there is no new supporting documentation the athlete can appeal to the Australian Sports Drug Medical Advisory Committee Review Panel who will consider the application that was not approved by ASDMAC (no new material can be added). Athletes can initiate this appeal by emailing firstname.lastname@example.org.
Should an athlete’s approved ASDMAC TUE not be recognised by an IF or MEO, the athlete, with assistance from ASDMAC, can appeal to WADA.